A Study of CT-868 in Type 1 Diabetes Mellitus

Clinical trial NCT06062069 · COMPLETED

Trial details

NCT number: NCT06062069
Sponsor: Carmot Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Overweight Obese Type 1 Diabetes Mellitus

Start date: 2023-10-19
Primary completion: 2025-07-09
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.